Skip to content
AidData logo

Overview

Chinese government provides anti-epidemic materials to the Central African Republic in March 2020

Commitments (Constant USD, 2023)$5,282
Commitment Year•2020Country of Activity•Central African RepublicDirect Recipient Country of Incorporation•Central African RepublicSector•HealthFlow Type•Grant

Status

Project lifecycle

Completion

Pipeline: PledgePipeline: CommitmentImplementationCompletion

Timeline

Key dates

Commitment date
Mar 20, 2020
Start (actual)
Mar 20, 2020
End (actual)
Mar 20, 2020

Stakeholders

Organizations involved in projects and activities supported by financial and in-kind transfers from Chinese government and state-owned entities

Funding agencies

Government Agencies

  • Unspecified Chinese Government Institution

Receiving agencies

Government Agencies

  • Central African Republic Ministry of Public Health and Population

Loan description

Chinese government provides anti-epidemic materials to the Central African Republic in March 2020

Narrative

Full Description

Project narrative

On March 23, 2020, the Chinese government provided anti-epidemic materials to the Central African Republic. These materials consisted of 4,000 gloves, 3,000 masks, 150 coveralls and 100 protective glasses. These materials will be distributed to various health centers for COVID-19 response efforts. The monetary value of this donation is unknown. A handover ceremony was held for this donation in Bangui, Central Africa. At the ceremony, China’s Ambassador to the Central African Republic, Chen Dong, handed over the materials to the President of the Central African Republic, Faustin-Archange Touadéra. The Ambassador of France, The Central African Minister of Health Pierre Somsé, Éric Gérard, and others also attended the ceremony.

Staff comments

1. The monetary value of this donation is unknown. AidData has estimated the transaction amount for this donation based on price catalogues from the World Health Organization (WHO). Please see the TUFF Methodology for additional details.